PUBLIC COMPANY
saveNEUROCRINE
USupdated 3mo ago
community read0 votes
pipeline
0
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(0)
no pipeline products on record
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2Pharmacokinetics, Safety and Tolerability of Crinecerfont in Participants With Congenital Adrenal Hyperplasia Who Are Less Than 2 Years Old
- phase4A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- phase3NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
🐶 Hiring Signal
News
- STAT+: PBMs agree to display TrumpRx drug pricesBristol's Zenbexus wins accelerated approval, Novartis wins UK patent fight over Entresto, and more biotech news from The Readoutstat · 1d ago
- STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug classThe FDA approved a treatment for advanced multiple myeloma made by Bristol Myers Squibb, marking the debut of a new class of drugs for the blood cancer.stat · 1d ago
- STAT+: Commure terminates payments under its customer referral programs tied to AI productsCommure, which develops and sells AI products to clinics, has terminated a program that paid for referrals to new customers.stat · 1d ago
- STAT+: Eli Lilly targets booming black market for retatrutideKhartis raises oral immunology funds, Neurocrine drug safety concerns, and more biotech news from The Readoutstat · 2d ago
- STAT+: Neurocrine Biosciences and the delicate balance of benefit and riskWhen it comes to rare disease treatments, patients often confront a difficult risk-benefit calculus. Such is the case with a therapy from Neurocrine Biosciences.stat · 2d ago
- Four questions on new safety warnings for Neurocrine’s Vykat XRA group of experts on Prader-Willi syndrome has sounded the alarm on side effects and deaths that may be connected to Neurocrine Biosciences’ medicine Vykat XR. The treatment has been linked to sev…endpoints · 2d ago
- Deaths reported after treatment with Neurocrine’s approved Prader-Willi drugReports of seven deaths in patients who had taken Neurocrine Biosciences’ Vykat and the official termination of Aardvark Therapeutics’ Phase 3 trial after cardiac complications marked a tough day f…biospace · 3d ago
- STAT+: Pharmalittle: We’re reading about Lilly ‘black market’ lawsuits, pushback over Trump vaccine plan, and moreEli Lilly filed six lawsuits against U.S. companies it accuses of illegally selling black-market versions of its experimental obesity drug retatrutidestat · 3d ago
- STAT+: Definium Therapeutics says its LSD therapy eased anxiety in late-stage trialDefinium Therapeutics said that its LSD therapy significantly helped patients with generalized anxiety disorder in the first of two large trials.stat · 3d ago
- STAT+: Biotech company co-founded by top autoimmune researcher lays out plans with antibody therapiesGerman researcher Georg Schett has made a name for himself as a pioneer in autoimmune disease treatment. Now he's co-founding his own company.stat · 3d ago
comments(0)
5-min edit window · permanent after that